Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Twenty One Capital Inc | Jack Mallers | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 6,089,634 | 6,089,634 | - | - | Stock Option (Right to Buy) | |
| Conduit Pharma Inc | Andrew James Regan | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 3,685,815 | 3,685,815 | - | - | Pre-Funded Warrants | |
| SKYX Platforms Corp | Rani R. Kohen | Director, Executive Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 1,500,000 | 1,500,000 | - | - | Stock Option (right to buy) | |
| Braze Inc (Class A) | Neeraj Agrawal | Director | 08 Dec 2025 | 1,235,865 | 0 | - | - | Class B Common Stock | ||
| Braze Inc (Class A) | Neeraj Agrawal | Director | 08 Dec 2025 | 1,235,865 | 1,238,741 | - | - | Class A Common Stock | ||
| Braze Inc (Class A) | Neeraj Agrawal | Director | 08 Dec 2025 | 1,189,541 | 0 | - | - | Class B Common Stock | ||
| Braze Inc (Class A) | Neeraj Agrawal | Director | 08 Dec 2025 | 1,189,541 | 1,192,309 | - | - | Class A Common Stock | ||
| Golden Matrix Grp Inc | Anthony Brian Goodman | Ten Percent Owner, Former Director and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 1,000,000 | 9,704,079 | - | - | Common Stock | |
| Asana Inc (Class A) | Justin Rosenstein | Director | Sale of securities on an exchange or to another person at price $ 15.12 per share. | 08 Dec 2025 | 850,233 | 210,398 | - | 15.1 | 12,855,438 | Class A Common Stock |
| Butterfly Network Inc (Class A) | Jonathan M. Rothberg | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.27 per share. | 08 Dec 2025 | 543,601 | 0 | - | 3.3 | 1,779,043 | Class A Common Stock |
| Hewlett Packard | Antonio Fabio Neri | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 421,731 | 421,731 | - | - | Restricted Stock Units | |
| LoanDepot Inc (Class A) | Anthony Li Hsieh | Director, Executive Chair, CEO & Pres., Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.67 per share. | 08 Dec 2025 | 399,919 | 1,530,815 (2%) | 0% | 2.7 | 1,068,184 | Class A Common Stock |
| Sotera Health Co | Michael B. Petras | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 16.45 per share. | 08 Dec 2025 | 394,861 | 4,819,393 | - | 16.4 | 6,495,463 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 08 Dec 2025 | 387,946 | 82,854 (0%) | 0% | 0 | Common Stock | |
| LoanDepot Inc (Class A) | Anthony Li Hsieh | Director, Executive Chair, CEO & Pres., Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.81 per share. | 08 Dec 2025 | 369,266 | 1,930,734 (3%) | 0% | 2.8 | 1,036,899 | Class A Common Stock |
| Hudson Global Inc | Jeffrey E. Eberwein | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.35 per share. | 08 Dec 2025 | 320,855 | 810,217 | - | 9.3 | 2,999,994 | Series A Preferred Stock |
| Wolfspeed Inc | Robert Feurle | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 317,327 | 317,327 (0%) | 0% | 0 | COMMON STOCK | |
| Sotera Health Co | Michael B. Petras | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 16.45 per share. | 08 Dec 2025 | 315,896 | 552,790 | - | 16.4 | 5,196,489 | Common Stock, $0.01 par value per share ("Common Stock") |
| Braze Inc (Class A) | Neeraj Agrawal | Director | 08 Dec 2025 | 314,301 | 0 | - | - | Class B Common Stock | ||
| Braze Inc (Class A) | Neeraj Agrawal | Director | 08 Dec 2025 | 314,301 | 315,033 | - | - | Class A Common Stock | ||
| Golden Matrix Grp Inc | Anthony Brian Goodman | Ten Percent Owner, Former Director and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 300,000 | 0 | - | - | Restricted Stock Unit | |
| Golden Matrix Grp Inc | Anthony Brian Goodman | Ten Percent Owner, Former Director and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 300,000 | 8,704,079 | - | - | Common Stock | |
| Hudson Global Inc | Jeffrey E. Eberwein | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 10.43 per share. | 08 Dec 2025 | 287,631 | 990,847 (33%) | 9% | 10.4 | 2,999,991 | Common Stock |
| SoFi Tech Inc | Jeremy Rishel | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 271,751 | 808,450 | - | - | Restricted Stock Unit | |
| SoFi Tech Inc | Jeremy Rishel | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 271,751 | 1,033,579 | - | - | Common Stock | |
| Braze Inc (Class A) | Neeraj Agrawal | Director | 08 Dec 2025 | 267,977 | 0 | - | - | Class B Common Stock | ||
| Braze Inc (Class A) | Neeraj Agrawal | Director | 08 Dec 2025 | 267,977 | 268,601 | - | - | Class A Common Stock | ||
| HP Inc. | Enrique J. Lores | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 263,696 | 263,696 | - | - | Restricted Stock Units | |
| Butterfly Network Inc (Class A) | Jonathan M. Rothberg | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.27 per share. | 08 Dec 2025 | 225,726 | 287,101 | - | 3.3 | 738,733 | Class A Common Stock |
| Conduit Pharma Inc | Andrew James Regan | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 1.79 per share. | 08 Dec 2025 | 224,800 | 227,304 | - | 1.8 | 402,392 | Common Stock |
| Sprinklr Inc (Class A) | Yvette M. Kanouff | Director | 08 Dec 2025 | 221,968 | 0 | - | - | Class B Common Stock | ||
| Sprinklr Inc (Class A) | Yvette M. Kanouff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 221,968 | 0 | - | - | Stock Option (right to buy) | |
| Sprinklr Inc (Class A) | Yvette M. Kanouff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 221,968 | 221,968 | - | - | Class B Common Stock | |
| Sprinklr Inc (Class A) | Yvette M. Kanouff | Director | 08 Dec 2025 | 221,968 | 356,154 | - | - | Class A Common Stock | ||
| Alphatec Holdings Inc | David R. Pelizzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 21.20 per share. | 08 Dec 2025 | 221,166 | 10,673,879 (17%) | 0% | 21.2 | 4,688,719 | Common Stock |
| Alphatec Holdings Inc | Jennifer N. Pritzker | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 21.20 per share. | 08 Dec 2025 | 221,166 | 10,673,879 (17%) | 0% | 21.2 | 4,688,719 | Common Stock |
| SEMrush Holdings Inc (Class A) | Andrew Warden | Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 11.84 per share. | 08 Dec 2025 | 196,115 | 241,083 | - | 11.8 | 2,322,003 | Class A Common Stock |
| Universal Technical Institute Inc | Jerome A. Grant | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 194,394 | 539,018 (1%) | 0% | 0 | Common Stock, $0.0001 par value | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 08 Dec 2025 | 193,973 | 218,223 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 08 Dec 2025 | 193,973 | 218,223 (0%) | 0% | 0 | Common Stock | |
| Hewlett Packard | Marie Myers | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 193,839 | 193,839 | - | - | Restricted Stock Units | |
| Nerdy Inc (Class A) | Charles Cohn | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.33 per share. | 08 Dec 2025 | 184,491 | 31,784,341 | - | 1.3 | 245,373 | Class A Common Stock |
| Sphere 3D Corp | Kurt L. Kalbfleisch | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 183,594 | 648,964 (17%) | 4% | - | Common Stock | |
| Sphere 3D Corp | Kurt L. Kalbfleisch | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 183,594 | 976,561 | - | - | Restricted Stock Unit (RSU) | |
| Huntington Bancshares | Stephen D. Steinour | Director, President, CEO & Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Dec 2025 | 180,000 | 1,408,763 (0%) | 0% | 0 | Common Stock | |
| Hewlett Packard | John Francis Schultz | EVP, COLO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 178,122 | 178,122 | - | - | Restricted Stock Units | |
| Butterfly Network Inc (Class A) | Jonathan M. Rothberg | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.11 per share. | 08 Dec 2025 | 176,070 | 111,031 | - | 3.1 | 546,768 | Class A Common Stock |
| Rush Street Interactive Inc (Class A) | Richard Schwartz | Director, Chief Executive Officer | 08 Dec 2025 | 172,781 | 648,726 | - | 0 | Class A Common Stock | ||
| Rush Street Interactive Inc (Class A) | Richard Schwartz | Director, Chief Executive Officer | 08 Dec 2025 | 172,781 | 5,373,331 | - | - | Class A Common Units of Rush Street Interactive, L.P. | ||
| Rush Street Interactive Inc (Class A) | Richard Schwartz | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 08 Dec 2025 | 172,781 | 5,373,331 | - | 0 | Class V Voting Stock | |
| Wolfspeed Inc | Gregor van Issum | CFO & Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 172,263 | 172,263 (0%) | 0% | 0 | COMMON STOCK | |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 168,231 | 76,469 | - | - | Share Option (right to buy) | |
| MGP Ingredients Inc | Karen L Seaberg | Director | Sale of securities on an exchange or to another person at price $ 24.24 per share. | 08 Dec 2025 | 166,668 | 116,901 (0%) | 0% | 24.2 | 4,040,032 | common stock |
| Hewlett Packard | Antonio Fabio Neri | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 160,211 | 0 | - | - | Restricted Stock Units | |
| Hewlett Packard | Antonio Fabio Neri | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.86 per share. | 08 Dec 2025 | 160,211 | 2,103,192 (0%) | 0% | 23.9 | 3,822,634 | Common Stock |
| Cedar Fair L.P. | John T. Reilly | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 159,847 | 159,847 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Immix Biopharma Inc | Gabriel Morris | Director, CFO | 08 Dec 2025 | 156,000 | 426,844 | - | 0.8 | 124,800 | Common Stock | |
| SoFi Tech Inc | Jeremy Rishel | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.26 per share. | 08 Dec 2025 | 151,937 | 886,434 | - | 26.3 | 3,989,562 | Common Stock |
| Hewlett Packard | Fidelma Russo | EVP, GM, Hybrid Cloud & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 146,689 | 146,689 | - | - | Restricted Stock Units | |
| Hewlett Packard | Neil B. MacDonald | EVP, GM, Server | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 146,689 | 146,689 | - | - | Restricted Stock Units | |
| Airbnb | Nathan Blecharczyk | Director, Chief Strategy Officer, Ten Percent Owner | 08 Dec 2025 | 141,063 | 152,583 | - | - | Class A Common Stock | ||
| Airbnb | Nathan Blecharczyk | Director, Chief Strategy Officer, Ten Percent Owner | 08 Dec 2025 | 141,063 | 46,090,567 | - | - | Class B Common Stock | ||
| Turning Point Brands Inc | Graham A. Purdy | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 08 Dec 2025 | 140,140 | 140,140 | - | - | Forward contract | |
| Rush Street Interactive Inc (Class A) | Richard Schwartz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 18.37 per share. | 08 Dec 2025 | 134,148 | 514,578 | - | 18.4 | 2,464,500 | Class A Common Stock |
| Broadcom | Henry Samueli | Director | Sale of securities on an exchange or to another person at price $ 401.02 per share. | 08 Dec 2025 | 131,375 | 37,377,099 (9%) | 0% | 401.0 | 52,684,003 | Common Stock, $0.001 par value |
| HP Inc. | Karen L. Parkhill | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 130,826 | 130,826 | - | - | Restricted Stock Units | |
| Shift4 Payments Inc (Class A) | Jared Isaacman | Director, Executive Chairman, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Dec 2025 | 130,257 | 951,487 | - | 0 | Class C Common Stock | |
| MoonLake Immunotherapeutics (Class A) | Jorge Santos da Silva | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.08 per share. | 08 Dec 2025 | 130,000 | 2,948,577 | - | 15.1 | 1,960,400 | Class A ordinary shares, par value $0.0001 per share |
| MoonLake Immunotherapeutics (Class A) | Kristian Reich | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 15.08 per share. | 08 Dec 2025 | 130,000 | 72,908 | - | 15.1 | 1,960,400 | Class A ordinary shares, par value $0.0001 per share |
| Shift4 Payments Inc (Class A) | Jared Isaacman | Director, Executive Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 127,620 | 1,079,107 | - | 0 | Class A Common Stock | |
| Wolfspeed Inc | David T. Emerson | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 126,931 | 127,109 (0%) | 0% | 0 | COMMON STOCK | |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 125,300 | 161,100 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 14.19 per share. | 08 Dec 2025 | 122,349 | 25,000 (0%) | 0% | 14.2 | 1,736,744 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 08 Dec 2025 | 122,349 | 147,349 (0%) | 0% | 4.8 | 581,158 | Ordinary Shares |
| Sprinklr Inc (Class A) | Yvette M. Kanouff | Director | Sale of securities on an exchange or to another person at price $ 7.86 per share. | 08 Dec 2025 | 116,226 | 239,928 | - | 7.9 | 913,536 | Class A Common Stock |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 14.56 per share. | 08 Dec 2025 | 107,400 | 25,000 (0%) | 0% | 14.6 | 1,563,314 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.87 per share. | 08 Dec 2025 | 107,400 | 132,400 (0%) | 0% | 3.9 | 415,638 | Ordinary Shares |
| BioCardia Inc | Peter Altman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 1.37 per share. | 08 Dec 2025 | 106,588 | 323,350 (4%) | 1% | 1.4 | 146,026 | Common Stock |
| CoreWeave Inc (Class A) | Brannin McBee | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 83.80 per share. | 08 Dec 2025 | 102,835 | 185,181 | - | 83.8 | 8,617,923 | Class A Common Stock |
| CoreWeave Inc (Class A) | Brannin McBee | Chief Development Officer | 08 Dec 2025 | 102,835 | 288,016 | - | - | Class A Common Stock | ||
| CoreWeave Inc (Class A) | Brannin McBee | Chief Development Officer | 08 Dec 2025 | 102,835 | 9,219,990 | - | - | Class B Common Stock | ||
| Kymera Therapeutics Inc | Nello Mainolfi | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 89.17 per share. | 08 Dec 2025 | 100,000 | 660,482 | - | 89.2 | 8,917,000 | Common Stock |
| Kymera Therapeutics Inc | Nello Mainolfi | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.08 per share. | 08 Dec 2025 | 100,000 | 760,482 | - | 2.1 | 208,000 | Common Stock |
| Kymera Therapeutics Inc | Nello Mainolfi | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 100,000 | 305,559 | - | - | Stock Option (Right to Buy) | |
| Calavo Growers Inc | B. John Lindeman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Wave Life Sciences Ltd | Kyle Moran | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 100,000 | 75,000 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Kyle Moran | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.14 per share. | 08 Dec 2025 | 100,000 | 189,218 (0%) | 0% | 3.1 | 314,000 | Ordinary Shares |
| Evommune Inc | Eugene A. Bauer | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 100,000 | 100,000 | - | - | Employee Stock Option (Right to Buy) | |
| Hewlett Packard | Fidelma Russo | EVP, GM, Hybrid Cloud & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.86 per share. | 08 Dec 2025 | 99,747 | 190,083 (0%) | 0% | 23.9 | 2,379,963 | Common Stock |
| Hewlett Packard | Fidelma Russo | EVP, GM, Hybrid Cloud & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 99,747 | 0 | - | - | Restricted Stock Units | |
| Immix Biopharma Inc | Gabriel Morris | Director, CFO | 08 Dec 2025 | 96,000 | 0 | - | - | Warrants (right to purchase) | ||
| Levi Strauss & Co. - Ordinary Shares Cls A | Joshua E. Prime | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Dec 2025 | 95,721 | 48,063 | - | - | Class B Common Stock | |
| HP Inc. | David P. McQuarrie | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 93,540 | 93,540 | - | - | Restricted Stock Units | |
| Sphere 3D Corp | Kurt L. Kalbfleisch | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.47 per share. | 08 Dec 2025 | 90,000 | 558,964 (14%) | 2% | 0.5 | 41,922 | Common Stock |
| HP Inc. | Anneliese Olson | Pres Imaging Prtng & Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 88,471 | 88,471 | - | - | Restricted Stock Units | |
| American International | Peter S. Zaffino | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 85,403 | 694,609 (0%) | 0% | 0 | Common Stock | |
| American International | Peter S. Zaffino | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 85,403 | 0 | - | - | Restricted Stock Units | |
| Entravision Comm Corp (Class A) | Jeffery A. Liberman | President and COO | Sale of securities on an exchange or to another person at price $ 3.29 per share. | 08 Dec 2025 | 85,108 | 126,316 (0%) | 0% | 3.3 | 279,912 | Class A common stock |
| SEMrush Holdings Inc (Class A) | Andrew Warden | Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.78 per share. | 08 Dec 2025 | 84,585 | 437,199 | - | 9.8 | 827,241 | Class A Common Stock |
| SEMrush Holdings Inc (Class A) | Andrew Warden | Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 84,585 | 42,803 | - | - | Employee Stock Option (Right to Buy) | |
| Airbnb | Nathan Blecharczyk | Director, Chief Strategy Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 121.63 per share. | 08 Dec 2025 | 84,516 | 68,067 | - | 121.6 | 10,279,461 | Class A Common Stock |
| Hewlett Packard | Kirt P. Karros | SVP, Treasurer, Corp Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 83,822 | 83,822 | - | - | Restricted Stock Units | |
| Okta Inc (Class A) | Jacques Frederic Kerrest | Director | 08 Dec 2025 | 83,500 | 83,500 (0%) | 0% | 0 | Class A Common Stock | ||
| Okta Inc (Class A) | Jacques Frederic Kerrest | Director | 08 Dec 2025 | 83,500 | 843,487 | - | - | Class B Common Stock | ||
| Okta Inc (Class A) | Jacques Frederic Kerrest | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Dec 2025 | 83,000 | 500 (0%) | 0% | 0 | Class A Common Stock | |
| DENTSPLY Sirona Inc | Gregory T. Lucier | Director | Sale of securities on an exchange or to another person at price $ 11.14 per share. | 08 Dec 2025 | 82,200 | 0 (0%) | 0% | 11.1 | 915,708 | Common Stock |
| Navitas Semiconductor Corp | Todd Glickman | Sr. V.P., CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 9.77 per share. | 08 Dec 2025 | 78,307 | 813,279 | - | 9.8 | 765,091 | Class A Common Stock |
| Sprinklr Inc (Class A) | Yvette M. Kanouff | Director | 08 Dec 2025 | 78,032 | 175,349 | - | - | Class A Common Stock | ||
| Sprinklr Inc (Class A) | Yvette M. Kanouff | Director | 08 Dec 2025 | 78,032 | 0 | - | - | Class B Common Stock | ||
| Sprinklr Inc (Class A) | Yvette M. Kanouff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 78,032 | 78,032 | - | - | Class B Common Stock | |
| Sprinklr Inc (Class A) | Yvette M. Kanouff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 78,032 | 221,968 | - | - | Stock Option (right to buy) | |
| Hewlett Packard | Stacy L. Dillow | EVP, Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 77,536 | 77,536 | - | - | Restricted Stock Units | |
| HP Inc. | Ketan M. Patel | President, Personal Systems | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 77,514 | 77,514 | - | - | Restricted Stock Units | |
| HP Inc. | Julie M. Jacobs | Chief Legal Officer and GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 77,351 | 77,351 | - | - | Restricted Stock Units | |
| Olema Pharma Inc | Shane Kovacs | CH. OPERATING & FINANCIAL OFF. | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Dec 2025 | 75,000 | 243,549 | - | 0 | Common Stock | |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 75,000 | 9,375 | - | - | Share Option (right to buy) | |
| Hewlett Packard | Jeremy K. Cox | SVP, Controller & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 73,345 | 73,345 | - | - | Restricted Stock Units | |
| 1stdibs.com Inc | David S. Rosenblatt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 5.96 per share. | 08 Dec 2025 | 73,207 | 1,976,786 | - | 6.0 | 436,314 | Common Stock |
| MoonLake Immunotherapeutics (Class A) | Kristian Reich | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 14.43 per share. | 08 Dec 2025 | 72,908 | 0 | - | 14.4 | 1,052,062 | Class A ordinary shares, par value $0.0001 per share |
| MoonLake Immunotherapeutics (Class A) | Jorge Santos da Silva | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.49 per share. | 08 Dec 2025 | 70,000 | 2,878,577 | - | 14.5 | 1,014,300 | Class A ordinary shares, par value $0.0001 per share |
| Broadcom | Henry Samueli | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Dec 2025 | 68,933 | 37,257,607 (9%) | 0% | 0 | Common Stock, $0.001 par value | |
| Hewlett Packard | John Francis Schultz | EVP, COLO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.86 per share. | 08 Dec 2025 | 68,471 | 407,156 (0%) | 0% | 23.9 | 1,633,718 | Common Stock |
| Hewlett Packard | John Francis Schultz | EVP, COLO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 68,471 | 0 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Darya Chudova | Chief Technology Officer | Other type of transaction at price $ 0.00 per share. | 08 Dec 2025 | 68,144 | 68,144 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Darya Chudova | Chief Technology Officer | Other type of transaction at price $ 0.00 per share. | 08 Dec 2025 | 68,144 | 21,734 (0%) | 0% | 0 | Common Stock | |
| Broadcom | Henry Samueli | Director | Sale of securities on an exchange or to another person at price $ 399.07 per share. | 08 Dec 2025 | 67,610 | 37,557,534 (9%) | 0% | 399.1 | 26,981,123 | Common Stock, $0.001 par value |
| Harley-Davidson Inc | Matthew A Ryan | Chief Marketing & Tech. Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 62,195 | 62,195 | - | - | Restricted Stock Units | |
| Village Farms Intl Inc | Orville Bovenschen | President of Canadian Cannabis | Sale of securities on an exchange or to another person at price $ 3.30 per share. | 08 Dec 2025 | 61,586 | 50,000 (0%) | 0% | 3.3 | 203,234 | Common Shares |
| Starz Entertainment Corp | Jeffrey A. Hirsch | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 61,517 | 260,207 | - | 0 | Common Shares | |
| American Eagle Outfitters Inc | Marisa A. Baldwin | EVP - CHRO | Sale of securities on an exchange or to another person at price $ 22.41 per share. | 08 Dec 2025 | 61,319 | 23,364 (0%) | 0% | 22.4 | 1,374,159 | Common Stock, without par value |
| Immix Biopharma Inc | Gabriel Morris | Director, CFO | 08 Dec 2025 | 60,000 | 0 | - | - | Warrants (right to purchase) | ||
| Spruce Power Holding Corp (Class A) | Thomas J. Cimino | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 60,000 | 60,000 | - | 0 | Common Stock | |
| Wave Life Sciences Ltd | Kyle Moran | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.20 per share. | 08 Dec 2025 | 60,000 | 89,218 (0%) | 0% | 13.2 | 792,000 | Ordinary Shares |
| Wave Life Sciences Ltd | Kyle Moran | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.83 per share. | 08 Dec 2025 | 60,000 | 149,218 (0%) | 0% | 2.8 | 169,800 | Ordinary Shares |
| Wave Life Sciences Ltd | Kyle Moran | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 60,000 | 0 | - | - | Share Option (right to buy) | |
| Rush Street Interactive Inc (Class A) | Richard Schwartz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 18.82 per share. | 08 Dec 2025 | 59,757 | 454,821 | - | 18.8 | 1,124,669 | Class A Common Stock |
| Hewlett Packard | Antonio Fabio Neri | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.86 per share. | 08 Dec 2025 | 59,572 | 2,043,620 (0%) | 0% | 23.9 | 1,421,388 | Common Stock |
| Pure Storage Inc (Class A) | John Colgrove | Director, Chief Visionary Officer | Sale of securities on an exchange or to another person at price $ 71.09 per share. | 08 Dec 2025 | 58,780 | 41,220 (0%) | 0% | 71.1 | 4,178,670 | Class A Common Stock |
| BioCardia Inc | David McClung | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 1.37 per share. | 08 Dec 2025 | 58,276 | 106,226 (1%) | 0% | 1.4 | 79,838 | Common Stock |
| Hewlett Packard | Maeve C. Culloty | EVP, Pres & CEO Financial Serv | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 57,628 | 57,628 | - | - | Restricted Stock Units | |
| BioCardia Inc | Peter Altman | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.37 per share. | 08 Dec 2025 | 56,484 | 266,866 (3%) | 0% | 1.4 | 77,383 | Common Stock |
| Braze Inc (Class A) | Neeraj Agrawal | Director | 08 Dec 2025 | 55,137 | 60,607 | - | - | Class A Common Stock | ||
| Braze Inc (Class A) | Neeraj Agrawal | Director | 08 Dec 2025 | 55,137 | 0 | - | - | Class B Common Stock | ||
| Shift4 Payments Inc (Class A) | Jared Isaacman | Director, Executive Chairman, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.88 per share. | 08 Dec 2025 | 54,137 | 1,024,970 | - | 68.9 | 3,728,957 | Class A Common Stock |
| Hewlett Packard | Kirt P. Karros | SVP, Treasurer, Corp Dev | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.86 per share. | 08 Dec 2025 | 50,982 | 67,465 (0%) | 0% | 23.9 | 1,216,431 | Common Stock |
| Hewlett Packard | Kirt P. Karros | SVP, Treasurer, Corp Dev | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 50,982 | 0 | - | - | Restricted Stock Units | |
| Duolingo Inc (Class A) | Severin Hacker | Director, Chief Tech Officer, Co-Founder, Ten Percent Owner | 08 Dec 2025 | 50,000 | 50,072 | - | 0 | Class A Common Stock | ||
| Duolingo Inc (Class A) | Severin Hacker | Director, Chief Tech Officer, Co-Founder, Ten Percent Owner | 08 Dec 2025 | 50,000 | 2,836,917 | - | - | Class B Common Stock | ||
| Duolingo Inc (Class A) | Severin Hacker | Director, Chief Tech Officer, Co-Founder, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Dec 2025 | 50,000 | 72 | - | 0 | Class A Common Stock | |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 08 Dec 2025 | 50,000 | 25,000 (0%) | 0% | 16 | 800,000 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.48 per share. | 08 Dec 2025 | 50,000 | 75,000 (0%) | 0% | 10.5 | 524,000 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 50,000 | 0 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Kyle Moran | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.48 per share. | 08 Dec 2025 | 50,000 | 139,218 (0%) | 0% | 10.5 | 524,000 | Ordinary Shares |
| Wave Life Sciences Ltd | Kyle Moran | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 20.02 per share. | 08 Dec 2025 | 50,000 | 90,365 (0%) | 0% | 20.0 | 1,001,250 | Ordinary Shares |
| Wave Life Sciences Ltd | Kyle Moran | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 50,000 | 0 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Kyle Moran | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 50,000 | 222,700 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Kyle Moran | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 08 Dec 2025 | 50,000 | 139,218 (0%) | 0% | 15 | 750,000 | Ordinary Shares |
| Wave Life Sciences Ltd | Kyle Moran | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.20 per share. | 08 Dec 2025 | 50,000 | 89,218 (0%) | 0% | 13.2 | 660,000 | Ordinary Shares |
| Wave Life Sciences Ltd | Kyle Moran | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 08 Dec 2025 | 50,000 | 139,218 (0%) | 0% | 4.8 | 237,500 | Ordinary Shares |
| Wave Life Sciences Ltd | Kyle Moran | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 08 Dec 2025 | 50,000 | 89,218 (0%) | 0% | 18 | 900,000 | Ordinary Shares |
| Golden Matrix Grp Inc | Anthony Brian Goodman | Ten Percent Owner, Former Director and CEO | Sale of securities on an exchange or to another person at price $ 0.74 per share. | 08 Dec 2025 | 50,000 | 7,320,483 | - | 0.7 | 37,000 | Common Stock |
| Golden Matrix Grp Inc | Anthony Brian Goodman | Ten Percent Owner, Former Director and CEO | Sale of securities on an exchange or to another person at price $ 0.80 per share. | 08 Dec 2025 | 50,000 | 7,270,483 | - | 0.8 | 40,000 | Common Stock |
| AvePoint Inc (Class A) | Xunkai Gong | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 13.46 per share. | 08 Dec 2025 | 49,535 | 14,991,133 | - | 13.5 | 666,741 | Common Stock |
| Kymera Therapeutics Inc | Jared Gollob | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.33 per share. | 08 Dec 2025 | 49,307 | 159,299 | - | 5.3 | 262,806 | Common Stock |
| Kymera Therapeutics Inc | Jared Gollob | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 49,307 | 34,083 | - | - | Stock Option (Right to Buy) | |
| Broadcom | Henry Samueli | Director | Sale of securities on an exchange or to another person at price $ 400.11 per share. | 08 Dec 2025 | 49,060 | 37,508,474 (9%) | 0% | 400.1 | 19,629,397 | Common Stock, $0.001 par value |
| TriplePoint Venture Growth BDC Corp | James P. Labe | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.68 per share. | 08 Dec 2025 | 48,514 | 1,366,734 (4%) | 0% | 6.7 | 324,238 | Common Stock |
| TriplePoint Venture Growth BDC Corp | Sajal K. Srivastava | Director, President and CIO | Purchase of securities on an exchange or from another person at price $ 6.68 per share. | 08 Dec 2025 | 48,514 | 1,366,734 (4%) | 0% | 6.7 | 324,238 | Common Stock |
| Hewlett Packard | Neil B. MacDonald | EVP, GM, Server | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.86 per share. | 08 Dec 2025 | 47,713 | 167,517 (0%) | 0% | 23.9 | 1,138,432 | Common Stock |
| Hewlett Packard | Neil B. MacDonald | EVP, GM, Server | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 47,713 | 0 | - | - | Restricted Stock Units | |
| 1stdibs.com Inc | David S. Rosenblatt | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 47,500 | 617,500 | - | - | Restricted Stock Units | |
| 1stdibs.com Inc | David S. Rosenblatt | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 47,500 | 427,500 | - | - | Restricted Stock Units | |
| 1stdibs.com Inc | David S. Rosenblatt | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 47,500 | 2,049,993 | - | - | Common Stock | |
| 1stdibs.com Inc | David S. Rosenblatt | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 47,500 | 2,002,493 | - | - | Common Stock | |
| Airbnb | Nathan Blecharczyk | Director, Chief Strategy Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 122.27 per share. | 08 Dec 2025 | 46,537 | 21,530 | - | 122.3 | 5,690,172 | Class A Common Stock |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 14.50 per share. | 08 Dec 2025 | 45,882 | 25,000 (0%) | 0% | 14.5 | 665,289 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 08 Dec 2025 | 45,882 | 70,882 (0%) | 0% | 4.8 | 217,940 | Ordinary Shares |
| Universal Technical Institute Inc | Sherrell E. Smith | EVP, Chief Academic Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 45,358 | 179,489 (0%) | 0% | 0 | Common Stock, $0.0001 par value | |
| UiPath Inc (Class A) | Daniel Dines | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 19.21 per share. | 08 Dec 2025 | 45,000 | 29,198,585 | - | 19.2 | 864,608 | Class A Common Stock |
| Dominari Holdings Inc | Christopher Franklin Devall | COO | Sale of securities on an exchange or to another person at price $ 3.85 per share. | 08 Dec 2025 | 45,000 | 145,702 (3%) | 0% | 3.8 | 173,061 | Common Stock |
| Wave Life Sciences Ltd | Aik Na Tan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.58 per share. | 08 Dec 2025 | 45,000 | 70,400 (0%) | 0% | 4.6 | 206,325 | Ordinary Shares |
| Wave Life Sciences Ltd | Aik Na Tan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 45,000 | 0 | - | - | Share Option (right to buy) | |
| Confluent Inc (Class A) | Ryan Norris Mac Ban | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 29.77 per share. | 08 Dec 2025 | 44,114 | 336,950 | - | 29.8 | 1,313,274 | Class A Common Stock |
| PubMatic Inc Ordinary Shares | Rajeev K. Goel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 08 Dec 2025 | 44,000 | 44,000 | - | - | Class A Common Stock | ||
| PubMatic Inc Ordinary Shares | Rajeev K. Goel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 08 Dec 2025 | 44,000 | 210,984 | - | - | Class B Common Stock | ||
| PubMatic Inc Ordinary Shares | Rajeev K. Goel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 44,000 | 254,984 | - | - | Class B Common Stock | |
| PubMatic Inc Ordinary Shares | Rajeev K. Goel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 44,000 | 360,668 | - | - | Stock Option (Right to buy Class B Common Stock) | |
| PubMatic Inc Ordinary Shares | Rajeev K. Goel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.02 per share. | 08 Dec 2025 | 44,000 | 0 | - | 9.0 | 396,695 | Class A Common Stock |
| Kiniksa Pharma Ltd (Class A) | Mark Ragosa | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 41.49 per share. | 08 Dec 2025 | 42,841 | 31,086 (0%) | 0% | 41.5 | 1,777,473 | Class A Ordinary Share |
| Wave Life Sciences Ltd | Christian O. Henry | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 42,000 | 0 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Christian O. Henry | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.97 per share. | 08 Dec 2025 | 42,000 | 54,700 (0%) | 0% | 6.0 | 250,740 | Ordinary Shares |
| Wave Life Sciences Ltd | Christian O. Henry | Director | Sale of securities on an exchange or to another person at price $ 12.75 per share. | 08 Dec 2025 | 42,000 | 12,700 (0%) | 0% | 12.8 | 535,500 | Ordinary Shares |
| Wave Life Sciences Ltd | Adrian Rawcliffe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.97 per share. | 08 Dec 2025 | 42,000 | 54,700 (0%) | 0% | 6.0 | 250,740 | Ordinary Shares |
| Wave Life Sciences Ltd | Adrian Rawcliffe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 42,000 | 0 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Adrian Rawcliffe | Director | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 08 Dec 2025 | 42,000 | 12,700 (0%) | 0% | 15 | 630,000 | Ordinary Shares |
| American International | Peter S. Zaffino | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.31 per share. | 08 Dec 2025 | 41,789 | 652,820 (0%) | 0% | 76.3 | 3,188,919 | Common Stock |
| Hewlett Packard | Fidelma Russo | EVP, GM, Hybrid Cloud & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.86 per share. | 08 Dec 2025 | 41,740 | 148,343 (0%) | 0% | 23.9 | 995,916 | Common Stock |
| Sprinklr Inc (Class A) | Yvette M. Kanouff | Director | Sale of securities on an exchange or to another person at price $ 7.80 per share. | 08 Dec 2025 | 41,163 | 134,186 | - | 7.8 | 321,071 | Class A Common Stock |
| Alta Equipment Grp Inc (Class A) | Daniel Shribman | Director | Purchase of securities on an exchange or from another person at price $ 5.07 per share. | 08 Dec 2025 | 40,000 | 131,393 (0%) | 0% | 5.1 | 202,940 | Common Stock |
| Confluent Inc (Class A) | Neha Narkhede | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 40,000 | 1,123,729 | - | - | Class B Common Stock | |
| Confluent Inc (Class A) | Neha Narkhede | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 40,000 | 480,602 | - | - | Stock Option (Right to Buy) | |
| Confluent Inc (Class A) | Neha Narkhede | Director | Sale of securities on an exchange or to another person at price $ 29.77 per share. | 08 Dec 2025 | 40,000 | 28,549 | - | 29.8 | 1,190,800 | Class A Common Stock |
| Confluent Inc (Class A) | Neha Narkhede | Director | 08 Dec 2025 | 40,000 | 68,549 | - | - | Class A Common Stock | ||
| Confluent Inc (Class A) | Neha Narkhede | Director | 08 Dec 2025 | 40,000 | 1,083,729 | - | - | Class B Common Stock | ||
| Coinbase Global Inc (Class A) | Brian Armstrong | Director, Chairman and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.71 per share. | 08 Dec 2025 | 40,000 | 40,000 | - | 18.7 | 748,400 | Class A Common Stock |
| Coinbase Global Inc (Class A) | Brian Armstrong | Director, Chairman and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 40,000 | 2,633,924 | - | - | Employee Stock Option (right to buy) | |
| Carvana Co. (Class A) | Benjamin Huston | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.07 per share. | 08 Dec 2025 | 40,000 | 140,758 (0%) | 0% | 10.1 | 402,800 | Class A Common Stock |
| Carvana Co. (Class A) | Benjamin Huston | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 40,000 | 368,513 | - | - | Stock Options (Right to Buy) | |
| Carvana Co. (Class A) | Daniel Gill | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 429.00 per share. | 08 Dec 2025 | 40,000 | 231,106 (0%) | 0% | 429 | 17,160,000 | Class A Common Stock |
| Carvana Co. (Class A) | Daniel Gill | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 450.00 per share. | 08 Dec 2025 | 40,000 | 191,106 (0%) | 0% | 450 | 18,000,000 | Class A Common Stock |
| Fastly Inc (Class A) | Artur Bergman | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 10.66 per share. | 08 Dec 2025 | 40,000 | 2,850,579 (3%) | 0% | 10.7 | 426,400 | Class A Common Stock |
| NuScale Power Corp (Class A) | Robert Ramsey Hamady | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 40,000 | 185,625 | - | - | Employee Stock Option (right to buy) | |
| NuScale Power Corp (Class A) | Robert Ramsey Hamady | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 22.17 per share. | 08 Dec 2025 | 40,000 | 46,283 | - | 22.2 | 886,800 | Class A Common Stock |
| NuScale Power Corp (Class A) | Robert Ramsey Hamady | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.20 per share. | 08 Dec 2025 | 40,000 | 86,283 | - | 3.2 | 128,000 | Class A Common Stock |
| Entravision Comm Corp (Class A) | Jeffery A. Liberman | President and COO | Sale of securities on an exchange or to another person at price $ 3.11 per share. | 08 Dec 2025 | 39,441 | 211,424 (0%) | 0% | 3.1 | 122,594 | Class A common stock |
| Sotera Health Co | Michael B. Petras | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 16.45 per share. | 08 Dec 2025 | 39,243 | 0 | - | 16.4 | 645,547 | Common Stock |
| Universal Technical Institute Inc | Christopher E. Kevane | EVP and Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 38,878 | 112,555 (0%) | 0% | 0 | Common Stock, $0.0001 par value | |
| Universal Technical Institute Inc | Todd A. Hitchcock | EVP/COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 38,878 | 119,399 (0%) | 0% | 0 | Common Stock, $0.0001 par value | |
| SentinelOne Inc (Class A) | Tomer Weingarten | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 14.58 per share. | 08 Dec 2025 | 38,684 | 1,213,096 | - | 14.6 | 564,013 | Class A Common Stock |
| BioCardia Inc | Edward M. Gillis | Senior Vice President, Devices | Grant, award, or other acquisition of securities at price $ 1.37 per share. | 08 Dec 2025 | 38,078 | 47,046 (0%) | 0% | 1.4 | 52,167 | Common Stock |
| BioCardia Inc | Peter Altman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 38,000 | 90,215 | - | - | Stock Option (right to buy) | |
| 1stdibs.com Inc | David S. Rosenblatt | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 37,500 | 1,954,993 | - | - | Common Stock | |
| 1stdibs.com Inc | David S. Rosenblatt | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 37,500 | 187,500 | - | - | Restricted Stock Units | |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 14.08 per share. | 08 Dec 2025 | 37,500 | 25,000 (0%) | 0% | 14.1 | 528,000 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.14 per share. | 08 Dec 2025 | 37,500 | 62,500 (0%) | 0% | 3.1 | 117,750 | Ordinary Shares |
| AXT Inc | Morris S. Young | CEO | Sale of securities on an exchange or to another person at price $ 12.46 per share. | 08 Dec 2025 | 37,160 | 2,458,404 (6%) | 0% | 12.5 | 462,902 | Common Stock |
| Pure Storage Inc (Class A) | John Colgrove | Director, Chief Visionary Officer | Sale of securities on an exchange or to another person at price $ 71.52 per share. | 08 Dec 2025 | 36,819 | 4,401 (0%) | 0% | 71.5 | 2,633,295 | Class A Common Stock |
| Airbnb | Nathan Blecharczyk | Director, Chief Strategy Officer, Ten Percent Owner | 08 Dec 2025 | 36,370 | 46,054,197 | - | - | Class B Common Stock | ||
| Airbnb | Nathan Blecharczyk | Director, Chief Strategy Officer, Ten Percent Owner | 08 Dec 2025 | 36,370 | 47,890 | - | - | Class A Common Stock | ||
| Wave Life Sciences Ltd | Kyle Moran | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 36,000 | 0 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Kyle Moran | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.17 per share. | 08 Dec 2025 | 36,000 | 125,218 (0%) | 0% | 8.2 | 294,120 | Ordinary Shares |
| Rockwell | Blake D. Moret | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 35,849 | 35,849 | - | - | Employee Stock Option (Right to Buy) | |
| Usio Inc | Louis A. Hoch | Director, Chairman, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 1.42 per share. | 08 Dec 2025 | 35,433 | 3,196,001 (18%) | 0% | 1.4 | 50,315 | Common Stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 35,000 | 35,000 | - | - | Stock option (right to buy) | |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Sale of securities on an exchange or to another person at price $ 6.02 per share. | 08 Dec 2025 | 35,000 | 11,206 (0%) | 0% | 6.0 | 210,665 | Common Stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.11 per share. | 08 Dec 2025 | 35,000 | 46,206 (0%) | 0% | 2.1 | 73,850 | Common Stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Sale of securities on an exchange or to another person at price $ 5.95 per share. | 08 Dec 2025 | 35,000 | 11,206 (0%) | 0% | 6.0 | 208,250 | Common Stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.86 per share. | 08 Dec 2025 | 35,000 | 46,206 (0%) | 0% | 2.9 | 100,100 | Common Stock |
| Kingsway Fin Services Inc | Joseph D. Stilwell | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.82 per share. | 08 Dec 2025 | 35,000 | 666,904 (2%) | 0% | 12.8 | 448,700 | Common Stock |
| Telos Corp | Fredrick D. Schaufeld | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Dec 2025 | 35,000 | 216,818 | - | 0 | Common Stock | |
| Telos Corp | Fredrick D. Schaufeld | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Dec 2025 | 35,000 | 1,030,957 | - | 0 | Common Stock | |
| Telos Corp | Fredrick D. Schaufeld | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Dec 2025 | 35,000 | 1,065,957 | - | 0 | Common Stock | |
| Carvana Co. (Class A) | Daniel Gill | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.07 per share. | 08 Dec 2025 | 34,826 | 225,932 (0%) | 0% | 10.1 | 350,698 | Class A Common Stock |
| Carvana Co. (Class A) | Daniel Gill | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 34,826 | 200,902 | - | - | Stock Options (Right to Buy) | |
| Globus Medical Inc (Class A) | David C. Paul | Director, Executive Chairman, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 34,375 | 0 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc (Class A) | David C. Paul | Director, Executive Chairman, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.52 per share. | 08 Dec 2025 | 34,375 | 60,417 (0%) | 0% | 25.5 | 877,250 | Class A Common Stock |
| Broadcom | Henry Samueli | Director | Sale of securities on an exchange or to another person at price $ 402.09 per share. | 08 Dec 2025 | 33,746 | 37,343,353 (9%) | 0% | 402.1 | 13,568,929 | Common Stock, $0.001 par value |
| Liberty Global PLC (Class A) | Charles H.R. Bracken | EVP & CFO | Sale of securities on an exchange or to another person at price $ 11.18 per share. | 08 Dec 2025 | 33,220 | 0 (0%) | 0% | 11.2 | 371,506 | Class C Common Shares |
| American Eagle Outfitters Inc | Marisa A. Baldwin | EVP - CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.24 per share. | 08 Dec 2025 | 33,071 | 56,435 (0%) | 0% | 17.2 | 570,144 | Common Stock, without par value |
| American Eagle Outfitters Inc | Marisa A. Baldwin | EVP - CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 33,071 | 0 | - | - | Stock Option - Right to Buy | |
| HP Inc. | Manpreet S. Grewal | Global Controller and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 32,706 | 32,706 | - | - | Restricted Stock Units | |
| Cineverse Corp (Class A) | Peter C. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 32,413 | 160,361 (0%) | 0% | 0 | Class A Common Stock | |
| Cineverse Corp (Class A) | Patrick O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 32,413 | 160,906 (0%) | 0% | 0 | Class A Common Stock | |
| Cineverse Corp (Class A) | Mary Ann Halford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 32,413 | 277,961 (0%) | 0% | 0 | Class A Common Stock | |
| Wave Life Sciences Ltd | Aik Na Tan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.37 per share. | 08 Dec 2025 | 32,230 | 57,630 (0%) | 0% | 5.4 | 173,075 | Ordinary Shares |
| Wave Life Sciences Ltd | Aik Na Tan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 32,230 | 0 | - | - | Share Option (right to buy) | |
| Confluent Inc (Class A) | Michelangelo A. Volpi | Director | Sale of securities on an exchange or to another person at price $ 29.77 per share. | 08 Dec 2025 | 32,038 | 235,041 | - | 29.8 | 953,771 | Class A Common Stock |
| Frontier Comm Parent Inc | Scott C. Beasley | Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Dec 2025 | 31,575 | 235,885 | - | 0 | Common Stock | |
| MGP Ingredients Inc | Karen L Seaberg | Director | Sale of securities on an exchange or to another person at price $ 25.87 per share. | 08 Dec 2025 | 31,056 | 53,488 (0%) | 0% | 25.9 | 803,419 | common stock |
| Datadog Inc (Class A) | Alexis Le-Quoc | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 154.23 per share. | 08 Dec 2025 | 30,994 | 308,869 (0%) | 0% | 154.2 | 4,780,211 | Class A Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 105.34 per share. | 08 Dec 2025 | 30,760 | 172,463 (0%) | 0% | 105.3 | 3,240,172 | Common Stock |
| Guardant Health Inc | AmirAli Talasaz | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 105.34 per share. | 08 Dec 2025 | 30,760 | 172,463 (0%) | 0% | 105.3 | 3,240,172 | Common Stock |
| Annovis Bio Inc | Michael M.B. Hoffman | Director | Purchase of securities on an exchange or from another person at price $ 4.34 per share. | 08 Dec 2025 | 30,000 | 2,559,739 (39%) | 0% | 4.3 | 130,194 | Common Stock |
| Home Bancshares Inc | John W. Allison | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Dec 2025 | 30,000 | 5,510,776 (3%) | 0% | 0 | Common Stock | |
| Wave Life Sciences Ltd | Christian O. Henry | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 30,000 | 15,000 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Christian O. Henry | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.58 per share. | 08 Dec 2025 | 30,000 | 42,700 (0%) | 0% | 4.6 | 137,550 | Ordinary Shares |
| Wave Life Sciences Ltd | Christian O. Henry | Director | Sale of securities on an exchange or to another person at price $ 18.02 per share. | 08 Dec 2025 | 30,000 | 12,700 (0%) | 0% | 18.0 | 540,600 | Ordinary Shares |
| MGP Ingredients Inc | Karen L Seaberg | Director | Sale of securities on an exchange or to another person at price $ 25.60 per share. | 08 Dec 2025 | 29,735 | 84,544 (0%) | 0% | 25.6 | 761,216 | common stock |
| MGP Ingredients Inc | Karen L Seaberg | Director | Sale of securities on an exchange or to another person at price $ 24.16 per share. | 08 Dec 2025 | 29,691 | 84,514 (0%) | 0% | 24.2 | 717,335 | common stock |
| Astrana Health Inc | Thomas S. Lam | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 29,502 | 0 | - | - | Stock Option (right to buy) | |
| Astrana Health Inc | Thomas S. Lam | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.78 per share. | 08 Dec 2025 | 29,502 | 459,122 (0%) | 0% | 17.8 | 524,546 | Common Stock |
| BioCardia Inc | David McClung | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.37 per share. | 08 Dec 2025 | 29,339 | 76,887 (1%) | 0% | 1.4 | 40,194 | Common Stock |
| Lemonade Inc | Adina Eckstein | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 29,237 | 4,514 | - | - | STOCK OPTION | |
| Lemonade Inc | Adina Eckstein | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 77.17 per share. | 08 Dec 2025 | 29,237 | 204,229 | - | 77.2 | 2,256,219 | COMMON STOCK |
| Lemonade Inc | Adina Eckstein | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 44.57 per share. | 08 Dec 2025 | 29,237 | 233,466 | - | 44.6 | 1,303,093 | COMMON STOCK |
| Hewlett Packard | Jean M. Hobby | Director | Sale of securities on an exchange or to another person at price $ 23.79 per share. | 08 Dec 2025 | 29,000 | 32,279 (0%) | 0% | 23.8 | 689,968 | Common Stock |
| Alphatec Holdings Inc | David R. Pelizzon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 21.03 per share. | 08 Dec 2025 | 28,834 | 10,645,045 (17%) | 0% | 21.0 | 606,379 | Common Stock |
| Alphatec Holdings Inc | Jennifer N. Pritzker | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 21.03 per share. | 08 Dec 2025 | 28,834 | 10,645,045 (17%) | 0% | 21.0 | 606,379 | Common Stock |
| Alphatec Holdings Inc | Patrick S. Miles | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.45 per share. | 08 Dec 2025 | 28,680 | 5,235,398 (8%) | 0% | 21.5 | 615,186 | Common Stock |
| American Eagle Outfitters Inc | Marisa A. Baldwin | EVP - CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.17 per share. | 08 Dec 2025 | 28,248 | 84,683 (0%) | 0% | 13.2 | 372,026 | Common Stock, without par value |
| American Eagle Outfitters Inc | Marisa A. Baldwin | EVP - CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 28,248 | 14,125 | - | - | Stock Option - Right to Buy | |
| Wyndham Hotels & Resorts Inc | Scott R. Strickland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 71.11 per share. | 08 Dec 2025 | 28,134 | 40,363 (0%) | 0% | 71.1 | 2,000,609 | Common Stock |
| Wyndham Hotels & Resorts Inc | Scott R. Strickland | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.40 per share. | 08 Dec 2025 | 28,134 | 68,497 (0%) | 0% | 53.4 | 1,502,356 | Common Stock |
| Wyndham Hotels & Resorts Inc | Scott R. Strickland | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 28,134 | 0 | - | - | Non-Qualified Stock Options | |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 14.50 per share. | 08 Dec 2025 | 28,125 | 25,000 (0%) | 0% | 14.5 | 407,813 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.14 per share. | 08 Dec 2025 | 28,125 | 53,125 (0%) | 0% | 3.1 | 88,313 | Ordinary Shares |
| Entravision Comm Corp (Class A) | Jeffery A. Liberman | President and COO | Sale of securities on an exchange or to another person at price $ 3.00 per share. | 08 Dec 2025 | 27,492 | 250,865 (0%) | 0% | 3.0 | 82,608 | Class A common stock |
| 1stdibs.com Inc | Thomas J. Etergino | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.96 per share. | 08 Dec 2025 | 27,066 | 266,885 | - | 6.0 | 161,313 | Common Stock |
| BioCardia Inc | David McClung | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 27,000 | 46,340 | - | - | Stock Option (right to buy) | |
| Fluence Energy Inc (Class A) | Julian Nebreda | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 26,144 | 182,911 | - | - | Class A Common Stock | |
| Fluence Energy Inc (Class A) | Julian Nebreda | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 26,144 | 26,144 | - | - | Restricted Stock Unit | |
| Astrana Health Inc | Thomas S. Lam | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.00 per share. | 08 Dec 2025 | 25,866 | 433,256 (0%) | 0% | 22 | 569,052 | Common Stock |
| Hewlett Packard | John Francis Schultz | EVP, COLO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.86 per share. | 08 Dec 2025 | 25,461 | 381,695 (0%) | 0% | 23.9 | 607,499 | Common Stock |
| Edwards Lifesciences | Bernard J. Zovighian | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.26 per share. | 08 Dec 2025 | 25,350 | 106,326 (0%) | 0% | 59.3 | 1,502,157 | Common Stock |
| Edwards Lifesciences | Bernard J. Zovighian | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 25,350 | 25,350 | - | - | Employee Stock Option (Right to Acquire) | |
| Carvana Co. (Class A) | Daniel Gill | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.03 per share. | 08 Dec 2025 | 25,283 | 251,215 (0%) | 0% | 42.0 | 1,062,644 | Class A Common Stock |
| Carvana Co. (Class A) | Daniel Gill | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 25,283 | 61,401 | - | - | Stock Options (Right to Buy) | |
| Hewlett Packard | Kirt P. Karros | SVP, Treasurer, Corp Dev | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.86 per share. | 08 Dec 2025 | 25,278 | 42,187 (0%) | 0% | 23.9 | 603,133 | Common Stock |
| Dominari Holdings Inc | Kyle Michael Wool | President | Purchase of securities on an exchange or from another person at price $ 3.87 per share. | 08 Dec 2025 | 25,000 | 2,453,817 (50%) | 0% | 3.9 | 96,798 | Common Stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Sale of securities on an exchange or to another person at price $ 5.95 per share. | 08 Dec 2025 | 25,000 | 11,206 (0%) | 0% | 5.9 | 148,650 | Common Stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.72 per share. | 08 Dec 2025 | 25,000 | 36,206 (0%) | 0% | 1.7 | 43,000 | Common Stock |
| Ceribell Inc | Josef Parvizi | Director | Sale of securities on an exchange or to another person at price $ 20.26 per share. | 08 Dec 2025 | 25,000 | 797,652 | - | 20.3 | 506,500 | Common Stock |
| Callan Jmb Inc | Liberty Smith Duke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 25,000 | 25,000 | - | - | Option (Right to Buy) | |
| CoreWeave Inc (Class A) | Brannin McBee | Chief Development Officer | 08 Dec 2025 | 25,000 | 4,216,020 | - | - | Class B Common Stock | ||
| CoreWeave Inc (Class A) | Brannin McBee | Chief Development Officer | 08 Dec 2025 | 25,000 | 5,950,000 | - | - | Class B Common Stock | ||
| CoreWeave Inc (Class A) | Brannin McBee | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 83.80 per share. | 08 Dec 2025 | 25,000 | 0 | - | 83.8 | 2,095,085 | Class A Common Stock |
| CoreWeave Inc (Class A) | Brannin McBee | Chief Development Officer | 08 Dec 2025 | 25,000 | 25,000 | - | - | Class A Common Stock | ||
| CoreWeave Inc (Class A) | Brannin McBee | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 83.80 per share. | 08 Dec 2025 | 25,000 | 0 | - | 83.8 | 2,095,085 | Class A Common Stock |
| CoreWeave Inc (Class A) | Brannin McBee | Chief Development Officer | 08 Dec 2025 | 25,000 | 25,000 | - | - | Class A Common Stock | ||
| Dominari Holdings Inc | Kyle Michael Wool | President | Purchase of securities on an exchange or from another person at price $ 3.87 per share. | 08 Dec 2025 | 25,000 | 1,211,828 (25%) | 0% | 3.9 | 96,798 | Common Stock |
| Macrogenics Inc | Beth Smith | VP, Controller & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 25,000 | 25,000 | - | - | Employee Stock Option (right to buy) | |
| Wave Life Sciences Ltd | Aik Na Tan | Director | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 08 Dec 2025 | 25,000 | 25,400 (0%) | 0% | 15 | 375,000 | Ordinary Shares |
| Dollar General | Donny H. Lau | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 24,572 | 39,809 (0%) | 0% | 0 | Common Stock | |
| Zeo Energy Corp (Class A) | Brandon Bridgewater | CSO | Sale of securities on an exchange or to another person at price $ 1.20 per share. | 08 Dec 2025 | 24,490 | 2,932,147 | - | 1.2 | 29,425 | Class A Common Stock |
| GCI Liberty Inc - Ordinary Shares - Series A | Richard R. Green | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 24,472 | 24,472 | - | - | Stock Option - GLIBK (Right to Buy) | |
| Viavi Soln Inc | Kevin Christopher Siebert | SVP Gen. Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 18.26 per share. | 08 Dec 2025 | 24,225 | 49,225 (0%) | 0% | 18.3 | 442,349 | Common Stock |
| Calavo Growers Inc | B. John Lindeman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 24,190 | 30,835 (0%) | 0% | 0 | Common Stock | |
| Pulmonx Corp | Daniel P. Florin | Director | Sale of securities on an exchange or to another person at price $ 1.99 per share. | 08 Dec 2025 | 23,321 | 93,910 | - | 2.0 | 46,409 | Common Stock |
| Dominari Holdings Inc | Anthony Hayes | CEO | Purchase of securities on an exchange or from another person at price $ 3.87 per share. | 08 Dec 2025 | 23,000 | 1,750,873 (36%) | 0% | 3.9 | 89,054 | Common Stock |
| Dominari Holdings Inc | Anthony Hayes | CEO | Purchase of securities on an exchange or from another person at price $ 3.87 per share. | 08 Dec 2025 | 23,000 | 1,750,873 (36%) | 0% | 3.9 | 89,054 | Common Stock |
| Hewlett Packard | Neil B. MacDonald | EVP, GM, Server | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.86 per share. | 08 Dec 2025 | 22,623 | 144,894 (0%) | 0% | 23.9 | 539,785 | Common Stock |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 14.08 per share. | 08 Dec 2025 | 22,500 | 25,000 (0%) | 0% | 14.1 | 316,800 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.83 per share. | 08 Dec 2025 | 22,500 | 47,500 (0%) | 0% | 2.8 | 63,675 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 22,500 | 0 | - | - | Share Option (right to buy) | |
| Alpha Metallurgical Resources Inc | Kenneth S. Courtis | Director | Purchase of securities on an exchange or from another person at price $ 175.92 per share. | 08 Dec 2025 | 22,413 | 769,882 (4%) | 0% | 175.9 | 3,942,895 | Common Stock, $0.01 par value per share |
| Hewlett Packard | Jeremy K. Cox | SVP, Controller & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 22,166 | 0 | - | - | Restricted Stock Units | |
| Hewlett Packard | Jeremy K. Cox | SVP, Controller & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.86 per share. | 08 Dec 2025 | 22,166 | 72,227 (0%) | 0% | 23.9 | 528,881 | Common Stock |
| Mitek Systems Inc | David B. Lyle | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 22,075 | 190,344 | - | - | Performance Restricted Stock Units | |
| Broadcom | Henry Samueli | Director | Sale of securities on an exchange or to another person at price $ 398.14 per share. | 08 Dec 2025 | 21,712 | 37,625,144 (9%) | 0% | 398.1 | 8,644,416 | Common Stock, $0.001 par value |
| Edwards Lifesciences | Bernard J. Zovighian | Director, CEO | Sale of securities on an exchange or to another person at price $ 85.21 per share. | 08 Dec 2025 | 21,487 | 84,839 (0%) | 0% | 85.2 | 1,831,006 | Common Stock |
| Cricut Inc (Class A) | Ashish Arora | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.97 per share. | 08 Dec 2025 | 21,294 | 4,344,586 | - | 5.0 | 105,818 | Class A Common Stock |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 21,000 | 3,517 | - | - | Stock Option | |
| United Therapeutics Corp | James C. Edgemond | CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 08 Dec 2025 | 21,000 | 29,142 (0%) | 0% | 146.0 | 3,066,630 | Common Stock |
| Wave Life Sciences Ltd | Aik Na Tan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 21,000 | 0 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Aik Na Tan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. | 08 Dec 2025 | 21,000 | 46,400 (0%) | 0% | 3.5 | 73,500 | Ordinary Shares |
| Wave Life Sciences Ltd | Aik Na Tan | Director | Sale of securities on an exchange or to another person at price $ 12.75 per share. | 08 Dec 2025 | 21,000 | 25,400 (0%) | 0% | 12.8 | 267,750 | Ordinary Shares |
| Wave Life Sciences Ltd | Aik Na Tan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.97 per share. | 08 Dec 2025 | 21,000 | 46,400 (0%) | 0% | 6.0 | 125,370 | Ordinary Shares |
| Wave Life Sciences Ltd | Aik Na Tan | Director | Sale of securities on an exchange or to another person at price $ 12.75 per share. | 08 Dec 2025 | 21,000 | 25,400 (0%) | 0% | 12.8 | 267,750 | Ordinary Shares |
| Wave Life Sciences Ltd | Aik Na Tan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 21,000 | 0 | - | - | Share Option (right to buy) | |
| Cricut Inc (Class A) | Ashish Arora | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.09 per share. | 08 Dec 2025 | 20,833 | 4,323,753 | - | 5.1 | 106,090 | Class A Common Stock |
| Cricut Inc (Class A) | Ashish Arora | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.12 per share. | 08 Dec 2025 | 20,833 | 4,302,920 | - | 5.1 | 106,748 | Class A Common Stock |
| Mitek Systems Inc | David B. Lyle | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.14 per share. | 08 Dec 2025 | 20,479 | 213,697 (0%) | 0% | 9.1 | 187,178 | Common Stock |
| Mission Produce Inc | Bruce C. Taylor | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Dec 2025 | 20,000 | 737,265 | - | 0 | COMMON STOCK | |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 20,000 | 20,000 | - | - | Stock option (right to buy) | |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 20,000 | 20,000 | - | - | Stock option (right to buy) | |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Sale of securities on an exchange or to another person at price $ 6.00 per share. | 08 Dec 2025 | 20,000 | 11,206 (0%) | 0% | 6.0 | 120,040 | Common Stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.11 per share. | 08 Dec 2025 | 20,000 | 31,206 (0%) | 0% | 1.1 | 22,200 | Common Stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Sale of securities on an exchange or to another person at price $ 5.96 per share. | 08 Dec 2025 | 20,000 | 11,206 (0%) | 0% | 6.0 | 119,240 | Common stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.98 per share. | 08 Dec 2025 | 20,000 | 31,206 (0%) | 0% | 2.0 | 39,600 | Common stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Sale of securities on an exchange or to another person at price $ 5.96 per share. | 08 Dec 2025 | 20,000 | 11,206 (0%) | 0% | 6.0 | 119,240 | Common Stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.11 per share. | 08 Dec 2025 | 20,000 | 31,206 (0%) | 0% | 2.1 | 42,200 | Common Stock |
| Arteris Inc | Antonio J. Viana | Director | Sale of securities on an exchange or to another person at price $ 18.01 per share. | 08 Dec 2025 | 20,000 | 164,620 | - | 18.0 | 360,194 | Common Stock |
| Axogen Inc | Lindsey Hartley | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 20,000 | 0 | - | - | Employee Stock Option (right to purchase) | |
| Axogen Inc | Lindsey Hartley | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.22 per share. | 08 Dec 2025 | 20,000 | 40,763 (0%) | 0% | 15.2 | 304,400 | Common Stock |
| BioCardia Inc | Edward M. Gillis | Senior Vice President, Devices | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 20,000 | 31,697 | - | - | Stock Option (right to buy) | |
| Carvana Co. (Class A) | Thomas Taira | President, Special Projects | Sale of securities on an exchange or to another person at price $ 429.00 per share. | 08 Dec 2025 | 20,000 | 80,832 (0%) | 0% | 429 | 8,580,000 | Class A Common Stock |
| Carvana Co. (Class A) | Thomas Taira | President, Special Projects | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.07 per share. | 08 Dec 2025 | 20,000 | 100,832 (0%) | 0% | 10.1 | 201,400 | Class A Common Stock |
| Carvana Co. (Class A) | Thomas Taira | President, Special Projects | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 20,000 | 161,282 | - | - | Stock Options (Right to Buy) | |
| Carvana Co. (Class A) | Benjamin Huston | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 450.00 per share. | 08 Dec 2025 | 20,000 | 100,758 (0%) | 0% | 450 | 9,000,000 | Class A Common Stock |
| Carvana Co. (Class A) | Benjamin Huston | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 429.00 per share. | 08 Dec 2025 | 20,000 | 120,758 (0%) | 0% | 429 | 8,580,000 | Class A Common Stock |
| Kingsway Fin Services Inc | Joseph D. Stilwell | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.80 per share. | 08 Dec 2025 | 20,000 | 646,904 (2%) | 0% | 12.8 | 256,000 | Common Stock |
| Wave Life Sciences Ltd | Aik Na Tan | Director | Sale of securities on an exchange or to another person at price $ 12.75 per share. | 08 Dec 2025 | 20,000 | 50,400 (0%) | 0% | 12.8 | 255,000 | Ordinary Shares |
| Intuit | Scott D. Cook | Director | Sale of securities on an exchange or to another person at price $ 656.45 per share. | 08 Dec 2025 | 19,767 | 5,937,221 (2%) | 0% | 656.5 | 12,976,104 | Common Stock |
| Alignment Healthcare Inc | Christopher J. Joyce | Chief Legal and Admin. Officer | Sale of securities on an exchange or to another person at price $ 19.33 per share. | 08 Dec 2025 | 19,706 | 323,886 | - | 19.3 | 380,905 | Common Stock |
| Datavault AI Inc | David Howitt | Director | Sale of securities on an exchange or to another person at price $ 1.63 per share. | 08 Dec 2025 | 19,656 | 311,909 (1%) | 0% | 1.6 | 32,090 | Common Stock |
| Stifel Fin Corp | Victor J. Nesi | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Dec 2025 | 19,401 | 41,975 (0%) | 0% | 0 | Common Stock | |
| Stifel Fin Corp | Victor J. Nesi | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Dec 2025 | 19,401 | 129,959 (0%) | 0% | 0 | Common Stock | |
| Digital Turbine Inc | Michael Akkerman | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.91 per share. | 08 Dec 2025 | 19,313 | 309,510 (0%) | 0% | 4.9 | 94,827 | Common Stock |
| Mitek Systems Inc | David B. Lyle | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.14 per share. | 08 Dec 2025 | 19,163 | 194,534 (0%) | 0% | 9.1 | 175,150 | Common Stock |
| SI-BONE Inc | Jeffrey W. Dunn | Director | Sale of securities on an exchange or to another person at price $ 19.33 per share. | 08 Dec 2025 | 18,759 | 110,115 (0%) | 0% | 19.3 | 362,606 | Common Stock |
| Rexford Industrial Realty Inc | Michael S. Frankel | Director, Co-CEO, Co-President | Sale of securities on an exchange or to another person at price $ 40.06 per share. | 08 Dec 2025 | 18,750 | 583,538 (0%) | 0% | 40.1 | 751,086 | Common Stock, par value $0.01 |
| Intuit | Scott D. Cook | Director | Sale of securities on an exchange or to another person at price $ 655.87 per share. | 08 Dec 2025 | 18,485 | 5,844,274 (2%) | 0% | 655.9 | 12,123,731 | Common Stock |
| Kymera Therapeutics Inc | Jared Gollob | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 88.02 per share. | 08 Dec 2025 | 18,357 | 127,183 | - | 88.0 | 1,615,811 | Common Stock |
| MGP Ingredients Inc | Karen L Seaberg | Director | Sale of securities on an exchange or to another person at price $ 26.31 per share. | 08 Dec 2025 | 18,203 | 35,285 (0%) | 0% | 26.3 | 478,921 | common stock |
| Zeo Energy Corp (Class A) | Brandon Bridgewater | CSO | Sale of securities on an exchange or to another person at price $ 1.16 per share. | 08 Dec 2025 | 18,191 | 2,913,956 | - | 1.2 | 21,136 | Class A Common Stock |
| Confluent Inc (Class A) | Michelangelo A. Volpi | Director | Sale of securities on an exchange or to another person at price $ 29.77 per share. | 08 Dec 2025 | 17,962 | 180,512 | - | 29.8 | 534,729 | Class A Common Stock |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 08 Dec 2025 | 17,900 | 25,000 (0%) | 0% | 15 | 268,500 | Ordinary Shares |
| Wave Life Sciences Ltd | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.87 per share. | 08 Dec 2025 | 17,900 | 42,900 (0%) | 0% | 3.9 | 69,273 | Ordinary Shares |
| Lemonade Inc | Adina Eckstein | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 78.97 per share. | 08 Dec 2025 | 17,799 | 227,987 | - | 79.0 | 1,405,587 | COMMON STOCK |
| Collegium pharma Inc | Scott Dreyer | EVP & Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 17,600 | 0 | - | - | Stock Option (Right to Purchase) | |
| Collegium pharma Inc | Scott Dreyer | EVP & Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.90 per share. | 08 Dec 2025 | 17,600 | 121,213 (0%) | 0% | 15.9 | 279,840 | Common Stock |
| Mach Natural Resources LP - Units | William W. McMullen | Director, Ten Percent Owner, See Remarks | Purchase of securities on an exchange or from another person at price $ 12.32 per share. | 08 Dec 2025 | 17,500 | 74,850,632 | - | 12.3 | 215,600 | Common Units |
| Wave Life Sciences Ltd | Aik Na Tan | Director | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 08 Dec 2025 | 17,230 | 25,400 (0%) | 0% | 15 | 258,450 | Ordinary Shares |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 16,790 | 73,210 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Sale of securities on an exchange or to another person at price $ 6.27 per share. | 08 Dec 2025 | 16,790 | 11,206 (0%) | 0% | 6.3 | 105,206 | Common Stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.16 per share. | 08 Dec 2025 | 16,790 | 27,996 (0%) | 0% | 4.2 | 69,846 | Common Stock |
| HP Inc. | Anneliese Olson | Pres Imaging Prtng & Solutions | Sale of securities on an exchange or to another person at price $ 24.83 per share. | 08 Dec 2025 | 16,726 | 169 (0%) | 0% | 24.8 | 415,307 | Common Stock |
| Datadog Inc (Class A) | Alexis Le-Quoc | Director, Chief Technology Officer | 08 Dec 2025 | 16,698 | 355,370 (0%) | 0% | 0 | Class A Common Stock | ||
| Datadog Inc (Class A) | Alexis Le-Quoc | Director, Chief Technology Officer | 08 Dec 2025 | 16,698 | 2,698,974 | - | - | Class B Common Stock | ||
| 1stdibs.com Inc | Thomas J. Etergino | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 16,563 | 33,125 | - | - | Restricted Stock Units | |
| 1stdibs.com Inc | Thomas J. Etergino | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 16,563 | 257,500 | - | - | Common Stock | |
| Lemonade Inc | Adina Eckstein | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.47 per share. | 08 Dec 2025 | 16,250 | 244,237 | - | 24.5 | 397,638 | COMMON STOCK |
| Lemonade Inc | Adina Eckstein | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 16,250 | 0 | - | - | STOCK OPTION | |
| Kiniksa Pharma Ltd (Class A) | Mark Ragosa | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 16,165 | 12,123 | - | - | Share Option | |
| Kiniksa Pharma Ltd (Class A) | Mark Ragosa | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.97 per share. | 08 Dec 2025 | 16,165 | 63,415 (0%) | 0% | 12.0 | 193,495 | Class A Ordinary Share |
| Kiniksa Pharma Ltd (Class A) | Mark Ragosa | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.10 per share. | 08 Dec 2025 | 16,164 | 47,250 (0%) | 0% | 11.1 | 179,420 | Class A Ordinary Share |
| Kiniksa Pharma Ltd (Class A) | Mark Ragosa | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 16,164 | 5,388 | - | - | Share Option |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.